Respiratory syncytial virus vaccine enters clinical testing
A Phase 1 clinical trial to test the safety and tolerability of an investigational vaccine against respiratory syncytial virus (RSV) has begun at the National Institutes of Health Clinical Center in Bethesda, Maryland. The ...
Feb 22, 2017
0
18